MICROVESICLE NUCLEIC ACIDS AND/OR PROTEINS AND USES THEREOF AS MARKERS OF RENAL TRANSPLANT REJECTION

摘要

The invention relates generally to the use of microvesicle biomarkers such as nucleic acids, including nucleic acid signatures, and/or proteins for assessing a kidney transplant rejection in a patient. The invention further relates to assessing, and/or to monitoring kidney transplant rejection in patients who have received a renal transplant.